Endoprosthetic elbow replacement in patients with solitary metastasis resulting from renal cell carcinoma

Rolf, Olaf; Gohlke, Frank

doi:10.1016/j.jse.2004.05.001

Cited by 14 publications

(11 citation statements)

References 25 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10 15 We used both the MSTS 93 and the MEPS to measure the arc of motion and lifting ability, which are both important factors for elbow functional evaluation. The function of patients with total humeral replacement could also be estimated using these 2 systems.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Tang

Guo

Yang

et al. 2009

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…This is because the elbow is an uncommon site for primary and metastatic bone tumors. 8,10 The options for reconstruction after excision of a tumor around the elbow are technically difficult and limited. Excisional arthroplasty or arthrodesis of the elbow always has poor function and is difficult in any patients with bone loss.…”

mentioning

confidence: 99%

Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Tang

Guo

Yang

et al. 2009

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

“…5 In the only reported cases of olecranon metastases, the primary cancers were renal cell carcinoma and multiple myeloma. 6,7 There is no precise account of just how rare olecranon metastases are but the literature suggests the frequency is somewhere between 2.5%-7% of all patients with cancer with distal skeletal metastases. 5 Once bone metastases are diagnosed in patients with renal cell carcinoma, the median survival for patients is 12 months.…”

Section: Discussionmentioning

confidence: 99%

Rare Bone Metastases of the Olecranon

Culleton

Christakis

et al. 2008

Journal of Palliative Medicine

View full text Add to dashboard Cite

Bone metastases are prevalent in patients with cancer, especially with primary lung, breast, renal cell, thyroid, and prostate carcinomas. When looking specifically at primary renal cell carcinoma, approximately 40% of patients will develop bone metastases during the course of their disease. However, distal bony involvement to the appendicular skeleton occurs less frequently, developing below the elbow and knee in approximately 7% of metastatic renal cell carcinoma patients. The incidence of olecranon metastasis is extremely rare in all cancers and so far only two cases have been reported in literature. We report the third case of an olecranon metastasis in a patient with renal cell carcinoma.

show abstract

“…22 Collis et al 23 reported a single patient who received a carbon fiber IM nail for treatment of a pathologic fracture of the humerus. 26 Rolf et al 27 reported four patients who received endoprosthetic elbow replacements for metastatic renal cell carcinoma. 23,24 Carbon fiber nails are not opaque to x-ray beams and do not introduce artifact on CT or MRI.…”

Section: Current Orthopaedic Practicementioning

confidence: 99%

Management of upper extremity bone metastases

Riediger

Evaniew

Ghert

2014

Current Orthopaedic Practice

View full text Add to dashboard Cite

Metastatic bone disease represents a significant burden of disease. Metastatic disease can seed in any bone of the body, but one of the most common long bones affected is the humerus. Although painful and often disabling, metastatic bone disease of the upper extremity often can be treated more conservatively than the lower extremity because of lower weight-bearing demands. However, the surgical management of upper extremity metastatic bone disease is an evolving field, and recent clinical studies have demonstrated several key principles. Intramedullary nailing and whole bone irradiation may be an optimal combination for prophylactic fixation. The addition of polymethyl methacrylate cement adds immediate stabilization to internal fixation and decreases postoperative pain. Plate and screw fixation can be used in lesions that cannot be treated with intramedullary nailing, but caution is necessary to avoid complications related to surgical technique. Finally, periarticular and intraarticular lesions may be managed with a hemi-or total-joint prosthesis for both the shoulder and elbow to provide the maximal functional outcome. Surgical intervention together with appropriate adjunctive therapies can decrease patient-important pain and skeletal-related events while improving quality of life in patients living with metastatic bone disease of the upper extremity. 1. Li S, Peng Y, Weinhandl ED, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol. 2012; 4:87--93. 2. von Moos R, Sternberg C, Body JJ, et al. Reducing the burden of bone metastases: Current concepts and treatment options.

show abstract

Endoprosthetic elbow replacement in patients with solitary metastasis resulting from renal cell carcinoma

Cited by 14 publications

References 25 publications

Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Custom-made prosthesis replacement for reconstruction of elbow after tumor resection

Rare Bone Metastases of the Olecranon

Management of upper extremity bone metastases

Contact Info

Product

Resources

About